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Protein-folding occurs in several intracellular locations including the endoplasmic reticulum
and mitochondria. In normal conditions there is a balance between the levels of unfolded
proteins and protein folding machinery. Disruption of homeostasis and an accumulation
of unfolded proteins trigger stress responses, or unfolded protein responses (UPR), in
these organelles. These pathways signal to increase the folding capacity, inhibit protein
import or expression, increase protein degradation, and potentially trigger cell death.
Many aging-related neurodegenerative diseases involve the accumulation of misfolded
proteins in both the endoplasmic reticulum and mitochondria. The exact participation of
the UPRs in the onset of neurodegeneration is unclear, but there is significant evidence
for the alteration of these pathways in the endoplasmic reticulum and mitochondria. Here
we will discuss the involvement of endoplasmic reticulum and mitochondrial stress and
the possible contributions of the UPR in these organelles to the development of two
neurodegenerative diseases, Parkinson’s disease (PD) and Alzheimer’s disease (AD).
Keywords: unfolded protein response, endoplasmic reticulum, mitochondria, Alzheimer’s disease, Parkinson’s
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INTRODUCTION
Proper protein folding is fundamental for cells to carry out nor-
mal functions and survive. The endoplasmic reticulum (ER)
is a specialized organelle that folds and modifies secretory
and integral membrane proteins. Mitochondria (MT) also con-
tain machinery to fold proteins encoded by the mitochondrial
genome or refold proteins imported into MT from the cytoplasm.
Disruption of protein folding homeostasis in these two organelles
results in the accumulation of misfolded proteins and induces
stress response pathways termed the unfolded protein responses
(ER-UPR and MT-UPR).
The loss of protein folding homeostasis and the intracellu-
lar deposition of aggregated proteins are pathologies common
to numerous neurodegenerative diseases. Insoluble protein aggre-
gates have been detected in PD and AD, among others. It remains
unknown whether these protein aggregates are the cause of cyto-
toxicity and disease or the by-product of a diseased state. There
is evidence, however, that unfolded protein response (UPR) path-
ways in the ER and in MT are either upregulated or abrogated in
many of these diseases. This raises the possibility that the accu-
mulation of unfolded proteins triggers stress-response pathways
that induce the neurotoxicity and cell death exhibited in brains
of afflicted patients. In this review we examine the ER- and MT-
UPRs and the evidence linking unfolded protein stress in these
organelles to neurodegenerative disease.
MISFOLDED PROTEIN STRESS IN THE ENDOPLASMIC
RETICULUM
PROTEIN FOLDING IN THE ER
Most secreted and plasma membrane proteins fold and mature
in the ER. Polypeptides are recognized in the cytoplasm by an
N-terminal signal peptide and are co-translationally imported
into the ER through the translocon pore, the SEC61 (secre-
tory 61) complex (Rapoport, 2007). The majority of proteins that
pass through the ER are met on the luminal side of the ER by
molecular chaperones and protein-modifying enzymes that fold
polypeptides modified by disulfide bond formation and append
chemical groups such as glycans to produce fully mature proteins
(Braakman and Bulleid, 2011). The highly conserved ER-resident
heat shock protein 70 (HSP70) family member BIP (binding
immunoglobulin protein, also called 78 kDa glucose-regulated
protein GRP78) is an essential protein that is thought to interact
with most nascent polypeptides as they enter the ER (Schroder
and Kaufman, 2005). BIP is aided in its protein folding functions
by various co-chaperones including the ER-localized J-proteins
(ERDJ1-5) that transfer newly imported polypeptides from the
translocon to BIP. While BIP does not actively fold proteins, it
is thought to maintain peptides in a folding-competent state by
binding and preventing aggregation during the folding process
(Gething, 1999; Schroder and Kaufman, 2005). Protein disulfide
isomerase (PDI) catalyzes and aids in disulfide bond formation
and chaperones such as the calcium-dependent calnexin and cal-
reticulin promote folding of glycosylated proteins (Braakman and
Bulleid, 2011).
Cells utilize several mechanisms to resolve aberrant folding or
modification of peptides in the ER. Protein folding appears to be a
kinetic process that is in constant competition with a degradation
pathway, or ER-associated degradation (ERAD) (Trombetta and
Parodi, 2003; Meusser et al., 2005; Braakman and Bulleid, 2011).
Protein misfolding affects the affinity of peptides for chaperones
and retards the folding process. Thus, a misfolded protein may be
re-folded by ER chaperones or, if caught in a misfolded state for
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too long, may be degraded via ERAD. The exact mechanisms by
which proteins are targeted to the ERAD pathway remain unclear,
but misfolded peptides are retrotranslocated across the ER mem-
brane by protein complexes including the Sec61 translocon. Once
in the cytoplasm, ERAD targets are met by ubiquitin conjugat-
ing enzymes and are degraded by the proteasomemachinery, thus
linking the activity of the ER to that of the ubiquitin-proteasome
system (UPS). Consistent with this, it has been found that inhibit-
ing the UPS with general proteasome inhibitors or mutated
proteins can cause the accumulation of unfolded proteins in the
ER (Bush et al., 1997; Lee et al., 2003).
THE ER-UPR
Protein folding in the ER is sensitive to various conditions
including the redox state of the environment, calcium concentra-
tions, and ATP levels (Figure 1) (Schroder and Kaufman, 2005).
Changes in these environmental conditions or the presence of a
chemical ER stressor such as tunicamycin, which inhibits protein
glycosylation, cause unfolded proteins to accumulate in the ER
and trigger the ER-UPR. In general, the ER-UPR is activated when
there is a loss in protein folding homeostasis and the quantity
of unfolded proteins outweighs the folding capacity of the ER.
The ER-UPR transmits the signal of unfolded protein stress from
the ER to the nucleus in an attempt to regain homeostasis by
increasing levels of protein folding and degradation machin-
ery while inhibiting general translation (Schroder and Kaufman,
2005). Under unmitigated ER stress, the ER-UPR can activate
apoptosis (Tabas and Ron, 2011).
Three transmembrane proteins have been identified as sen-
sors of unfolded proteins in the ER in mammalian cells: IRE1
(inositol-requiring protein 1), ATF6 (activating transcription fac-
tor 6) and PERK (protein kinase RNA-like ER kinase) (Figure 1)
(Schroder and Kaufman, 2005; Kohno, 2007, 2010). IRE1 and
PERK contain highly homologous ER luminal unfolded protein-
sensing domains and divergent cytosolic kinase domains. The
cytosolic domain of IRE1 is comprised of an endoribonu-
clease domain that, when IRE1 is active, participates in the
non-canonical splicing of cytosolic XBP1 (X-binding protein 1)
RNA (Sidrauski and Walter, 1997; Calfon et al., 2002). Spliced
XBP1 mRNA is translated into an active transcription factor
(Yoshida et al., 2001). Active PERK phosphorylates the alpha
subunit of eukaryotic initiation translation factor 2 (EIF2alpha)
FIGURE 1 | The Unfolded Protein Response in the ER. Several
environment alterations including changes in the cellular redox state, calcium
concentration, ATP concentration, and inhibition of protein glycosylation
affect the protein folding capacity of the ER. Three transmembrane
ER receptors, IRE1, ATF6, and PERK, sense unfolded proteins in the
lumen of the ER and promote the transcription of genes whose protein
products increase the folding capacity of the cell: ER chaperones [BIP,
calnexin, protein disulfide isomerase (PDI), and calreticulin], ER
biosynthetic machinery, and components of the ERAD degradation
pathway.
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promoting an inhibition of general translation and thereby reduc-
ing the protein burden on the ER. Under these conditions, CAP-
independent transcripts, including the transcription factor ATF4,
are preferentially translated (Ron andWalter, 2007). Upon detec-
tion of unfolded proteins, the third sensor ATF6 travels from the
ER membrane to the Golgi apparatus where it is cleaved by two
proteases, S1P (site 1 protease) and S2P (site 2 protease), releas-
ing the cytosolic ATF6 fragment, ATF6f (Figure 1). ATF6f is an
active transcription factor that shuttles to the nucleus to upregu-
late the expression of target genes. The three transcription factors
activated by the ER sensors, XBP1, ATF6f, and ATF4, individually
and combinatorially stimulate the expression of ER chaperones,
ER biosynthetic machinery, ERAD components, and apoptotic
signals in order to resolve ER stress (Figure 1).
THE ER-UPR INDUCES APOPTOSIS
In the event of chronic or unmitigated ER stress, the ER-UPR
triggers apoptosis by various means (Figure 2). One mechanism
involves the cleavage of the ER membrane associated caspase 12
initiating a cascade of caspase proteolysis that promotes apoptosis
(Szegezdi et al., 2003; Martinez et al., 2010; Tabas and Ron, 2011).
Cleavage of caspase 12 is caused by the release of calcium from
the ER, which under normal conditions serves as a reservoir for
cellular calcium. Signaling through the PERK branch of the UPR
also promotes apoptosis. The transcription factor ATF4 induces
the expression of a second transcription factor, CHOP (C/EBP-
homologous protein). CHOP inhibits the expression of anti-
apoptotic BCL 2 family proteins and activates the transcription of
pro-apoptotic BCL 2 family members (Figure 2). While the exact
mechanism is unclear, this transcriptional regulation of BCL 2
family members precipitates the post-translational activation of
two ER-localized BCL 2 family members, BAK and BAX (Kim
et al., 2009). Upon activation, these proteins re-localize to MT,
which leads to caspase activation and the release of pro-apoptotic
signals such as cytochrome c. Signaling through the IRE1 branch
of the ER-UPR can induce apoptosis through the association
of IRE1 with TNF-receptor-associated factor 2 (TRAF2) and
apoptosis-signal-regulating kinase (ASK1) under ER stress con-
ditions (Tabas and Ron, 2011). ASK1 enhances the pro-apoptotic
activity of BCL 2 family members through JNK signaling, while
TRAF2 induces the clustering and cleavage of caspase 12 (Yoneda
et al., 2001).
The ER-UPR is responsible for promoting cell survival by
increasing the folding capacity of the cell or for inducing cell
death depending on the type of stress. It is unclear how this bal-
ance between life and death is controlled, but the regulation of
FIGURE 2 | The induction of apoptosis by the ER and mitochondria.
Prolonged ER stress triggers apoptosis by mitochondria-dependent and
independent mechanisms. IRE1 and PERK signaling can induce apoptosis in
a mitochondria-dependent manner by activating the expression of
anti-apoptotic BCL 2 family proteins (green box) and inhibiting the expression
of pro-apoptotic BCL 2 family members (red box). Although the mechanism is
unclear, the regulation of BCL 2 family members precipitates the
post-translational activation of the ER-localized BCL 2 family members BAK
and BAX (dashed line), which re-localize to the mitochondria and lead to
caspase activation and the release of pro-apoptotic signals such as
cytochrome c. The release of calcium from the ER induces the cleavage of
the ER membrane-associated caspase 12 and the activation of the caspase
cascade that promotes apoptosis in a mitochondria-independent
manner.
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IRE1 binding partners may play an important role. The kinetics
of IRE1, ATF6, and PERK activation and inactivation are also
thought to affect the life and death output. IRE1 inactivation,
as determined by the diminution of XBP1 splicing, occurs on a
much shorter timescale than the inactivation of ATF6 or PERK, as
measured by the reduction in ATF6f and the attenuation of PERK
phosphorylation (Lin et al., 2007). This evokes a model in which
prolonged stress induces apoptosis through ATF6 and PERK.
However, understanding the totality of the ER-UPR requires
simultaneous investigation of all three branches under specific
stress conditions.
THE ER-UPR AND DISEASE
Due to the importance of protein folding for cellular function,
it is not surprising that the UPR is an essential pathway. It is
equally unsurprising the disruption or malfunction of the ER-
UPR may contribute to the onset of many diseases. Pancreatic
β-cells, for example, require a large folding and secretory capac-
ity to produce hormones and, therefore, depend on the ER-UPR
to maintain ER homeostasis (Lin et al., 2008). Increasing evi-
dence suggests that chronic ER stress in these cells leads to the
development of diabetes mellitus (Lin et al., 2008). Several types
of cancer including multiple myeloma are thought to depend
on the ER-UPR for survival (Lin et al., 2008; Michallet et al.,
2011). In such cases disrupting the ER-UPR could preferentially
kill cancer cells while causing little injury to normal tissue. Efforts
are currently underway to develop ER-UPR inhibitors to test
this hypothesis. Finally, numerous neurodegenerative diseases are
thought to involve protein misfolding and misregulation of the
ER-UPR. The contributions of ER stress in the pathogenesis of
the two most common neurodegenerative diseases, AD and PD,
will be discussed below in the section Misfolded proteins and
neurodegeneration.
MISFOLDED PROTEIN STRESS IN MITOCHONDRIA
PROTEIN IMPORT AND FOLDING IN MITOCHONDRIA
Mammalian MT contain 1000–1500 proteins, 13 of which are
encoded by the endogenous genome. These 13 proteins are
expressed and folded by mitochondrial machinery and function
as integral subunits of the electron transport chain. The remain-
ing mitochondrially localized proteins are nuclearly encoded
and are imported from the cytoplasm (Milenkovic et al., 2007).
Mitchondrially bound proteins are often recognized by import
machinery by a signal sequence. After translocation through the
outer membrane, polypeptides are delivered to their appropriate
destination and the signal sequences are cleaved.Othermitochon-
drial proteins that do not contain such pre-sequences are instead
recognized by other markers such as internal targeting sequences,
structure, or conserved cysteine motifs and are imported by an
array of protein complexes (Chacinska et al., 2009;Mokranjac and
Neupert, 2009).
Translocation into MT requires that proteins fully or par-
tially unfold prior to import (Eilers et al., 1988; Lithgow, 2000).
Imported proteins are refolded by resident mitochondrial molec-
ular chaperones such as HSP70 and HSP60 (heat shock protein
60) upon entry (Manning-Krieg et al., 1991; Hartl et al., 1992;
Deocaris et al., 2006). Mitochondrial HSP70 interacts directly
with incoming peptides on thematrix side of the inner membrane
and drives protein import with its ATPase activity. While both
mitochondrial HSP70 and HSP60 have roles in refolding newly
imported proteins, they have been shown recently to play addi-
tional roles in MT quality control (Raza et al., 2002; Zhao et al.,
2002; Yoneda et al., 2004).
Similarly to the ER, MT encounter stresses that can cause
the accumulation of misfolded or damaged proteins leading
to mitochondrial dysfunction. Such stress is reported to occur
during mitochondrial biogenesis when the accelerated input of
nuclear-encoded proteins may exceed the folding capacity of MT
(Tsang and Lemire, 2002; Benedetti et al., 2006; Durieux et al.,
2011). Misregulation of mitochondrial gene expression through
the mutation or loss of mitochondrial DNA (mtDNA) can
also result in the accumulation of unfolded proteins (Martinus
et al., 1996; Yoneda et al., 2004). Finally, the interior environ-
ment of MT is highly oxidative and mtDNA and mitochondri-
ally localized proteins can accrue oxidative damage over time.
MT have several mechanisms to combat the stress of dam-
aged or unfolded proteins and contain an array of molecular
chaperones and proteases that refold or degrade unfolded pro-
teins. One such mechanism that was described recently is the
MT-UPR.
THE MT-UPR
The MT-UPR (Figure 3) was first discovered in mammalian
cells using a system in which a mutant of the mitochondrially
localized enzyme ornithine transcarbamylase (OTC-) was over-
expressed (Zhao et al., 2002). This mutant is prone to misfold
and aggregate in MT. The mechanisms by which misfolded pro-
teins are detected in MT and how this signal is transmitted to
the nucleus remain unclear but accumulation of OTC- was
found to elicit the transcriptional upregulation of several genes
including that of the mitochondrial chaperone HSP60 and the
matrix-localized AAA protease CLPP (Zhao et al., 2002). Further
studies revealed that OTC- overexpression results in the upreg-
ulation of double-stranded RNA activated protein kinase (PKR)
expression, phosphorylation of EIF2alpha (Rath et al., 2011), and
the phosphorylation of c-JUN (Horibe and Hoogenraad, 2007).
Phosphorylated cJUN activates the transcription of CHOP and
C/EBPβ, which in turn activate the transcription of MT-UPR
responsive genes such as CLPP, HSP60, and the mitochondrial
chaperone MPPβ (Zhao et al., 2002; Horibe and Hoogenraad,
2007). Interestingly, MT-UPR responsive genes also contain two
other conserved elements, MURE1 and MURE2 (mitochondrial
unfolded protein response elements 1 and 2), but the proteins, if
any, that bind to these regions are yet to be discovered (Aldridge
et al., 2007).
A similar pathway was shown to exist in C. elegans (Figure 3).
Initial studies showed that chronic ethidium bromide treatment
to remove mtDNA and induce the accumulation of unfolded
proteins in MT resulted in the upregulation of mitochondrial
HSP60 expression (Yoneda et al., 2004). Unlike the mammalian
system, mitochondrial HSP70 (HSP-6 in worms) is also transcrip-
tionally activated under these conditions. Using a genome-wide
RNAi screening approach in worms that contain a construct of
GFP driven by the MT-UPR responsive hsp-60 promoter, authors
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FIGURE 3 | Model of the mitochondrial Unfolded Protein Response
(MT-UPR). Misregulation of import of nuclearly encoded mitochondrial
proteins, misregulation of mitochondrial gene expression or damage of
mtDNA or mitochondrially localized proteins can cause the accumulation of
misfolded or damaged proteins leading to mitochondrial stress. The MT-UPR
pathway is thought to restore protein folding homeostasis in MT. This
pathway has been described in mammalian cells and in C. elegans. Proteins
shown in gray are shared between the two models. Proteins in yellow are
unique to the mammalian model and proteins in green have only been
described in C. elegans.
uncovered several proteins that appear to be involved in the
pathway, including the worm CLPP ortholog CLPP-1 (Haynes
et al., 2007). Additionally, knocking down the expression of
ubiquitin-like protein 5 (UBL-5) (Benedetti et al., 2006), an ABC
transporter HAF-1 (Haynes et al., 2010), the homeobox DNA-
binding protein DVE-1 (Haynes et al., 2007) and a leucine zipper
protein ZC376.7 (Haynes et al., 2007) increased the expression
of the GFP reporter. The authors proposed a model in which
the protease CLPP-1 degrades misfolded proteins to small pep-
tides, which are transported into the cytoplasm through the
HAF-1 transporter triggering the relocalization of DVE-1, UBL-5,
and ZC376.7 to the nucleus (Figure 3) (Haynes and Ron, 2010).
DVE-1 and UBL-5 are known to form a complex and activate
the transcription of MT-UPR target genes. ZC376.7 is also a
transcription factor, but it is unknown whether it binds to the
DVE-1/UBL5 complex. Intriguingly, mammalian cells contain a
HAF-1 ortholog (ABCB10) in the inner membrane of the MT,
as well as orthologs of UBL-5 (UBL5) and DVE-1 (SATB2) that
form a complex in vivo (Haynes et al., 2007). It remains to be
seen whether these orthologs play similar roles in the mammalian
MT-UPR.
The intermembrane space (IMS)-localizedmitochondrial pro-
tease HTRA2/OMI has also been reported to be involved in
clearing unfolded proteins from the IMS of MT in mammalian
cells (Radke et al., 2008; Moisoi et al., 2009; Papa and Germain,
2011). Knocking out HTRA2/OMI in mice leads to the aggre-
gation of misfolded electron transport chain proteins in the
mitochondrial membrane (Moisoi et al., 2009). HTRA2/OMI
was also found to target misfolded endonuclease-G (endoG) in
the IMS (Radke et al., 2008; Papa and Germain, 2011). The
absence of HTRA2/OMI results in increased CHOP expression
and mitochondrial dysfunction suggesting that it is required for
cell survival (Moisoi et al., 2009).
Although many components participating in the MT-UPR
in mammalian cells and C. elegans have been identified, crucial
details about the pathway remain unknown. The mechanisms by
which unfolded proteins in MT are detected and recruit pro-
teases for degradation have not been determined. It is also unclear
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how mitochondrial peptides in the cytoplasm are sensed and
induce the nuclear relocalization of transcription factors. Finally,
although MT are critical for regulating apoptosis and controlling
cell life and death decisions, it is not well understood whether the
MT-UPR can induce apoptosis like the ER-UPR. However, several
lines of evidence suggest a connection. First, the accumulation of
unfolded proteins in MT upregulates the expression of CHOP,
which is important for inducing apoptosis by the ER-UPR. It is
possible that CHOP plays a similar role in the MT-UPR. Second,
mice containing a proofreading-deficient mtDNA polymerase g,
which results in increased levels of mtDNA mutations and is
thought to induce the MT-UPR, express high levels of apoptotic
markers (Kujoth et al., 2005). Third, recent studies of human
tumor cells indicate a relationship between folding environment
of the MT and apoptosis. In these studies, a mitochondrially tar-
geted small molecule heat shock protein 90 (HSP90) inhibitor was
used to disrupt protein folding specifically in MT (Kang et al.,
2009; Siegelin et al., 2011). Treatment with this compound led to
the induction of classic apoptotic markers and reduced cell viabil-
ity (Siegelin et al., 2011). While these data suggest an intriguing
link between protein folding in MT and the induction of apop-
tosis, further investigation is required to determine the exact
involvement of the MT-UPR.
MISFOLDED PROTEINS AND NEURODEGENERATION
Protein misfolding has long been implicated in neurodegen-
eration and the accumulation of protein aggregates has been
described in the pathology of numerous neurodegenerative
diseases. For example, insoluble deposits of [alpha]-synuclein
(α-syn) are found in neurons of patients with Parkinson’s dis-
ease (PD). Extracellular and intracellular plaques of amyloid beta
(Aβ) protein are archetypal indicators of Alzheimer’s disease
(AD). The presence of protein aggregates is also associated with
Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS),
and others. While the contribution of misfolded proteins to these
diseases remains controversial, studies of familial disease cases
have revealed that mutations in proteins found in aggregates, as
well as those involved in clearing unfolded proteins from the ER
and MT, are linked to disease incidence (Lindholm et al., 2006;
Reddy, 2009; Morais and de Strooper, 2010; Matus et al., 2011).
This suggests that protein misfolding contributes significantly to
the onset of some neurodegenerative diseases. Here we will review
data linking unfolded protein stress in the ER and in MT to the
onset or progression of PD and AD.
PARKINSON’S DISEASE
PD is characterized by the selective degeneration of dopaminergic
neurons in the substantia nigra pars compacta region of the brain-
stem (Olanow and Tatton, 1999; Schapira, 2006) and the disease
is accompanied by the accumulation within neurons of protein
aggregates termed Lewy bodies. These insoluble inclusions are
comprised of several proteins including α-syn (Spillantini et al.,
1997; Baba et al., 1998). The wild type function of α-syn is not
well understood, but it is thought to participate in presynap-
tic vesicle formation (Chandra et al., 2005). Genetic studies of
PD have uncovered mutations in α-syn itself that result in the
over-expression or misfolding of this major Lewy body compo-
nent (Polymeropoulos et al., 1997; Kruger et al., 1998; Singleton
et al., 2003; Zarranz et al., 2004; Simon-Sanchez et al., 2009).
While the toxicity of Lewy bodies and their contribution to the
onset and progression of PD is controversial, data from brains
of PD patients as well as animal and cellular models suggest that
these aggregates induce cellular stress responses and can induce
apoptosis (Dawson and Dawson, 2003).
PD and ER stress
Studies of PD reveal evidence that the ER is subject to unfolded
protein stress and suggest the involvement of ER-UPR signal-
ing in neuronal death (Figure 4). Aggregates of α-syn have been
localized to several cellular compartments including the ER and
have been found to induce ER stress (Bellucci et al., 2011).
Interestingly, over-expression of α-syn in yeast was found to
block vesicle trafficking from the ER to the Golgi (Cooper et al.,
2006). In the same study, co-overexpression of α-syn with pro-
teins involved in ER-to-Golgi vesicle fusion such as Rab guanosine
triphosphatases (GTPase), was found to suppress the trafficking
defect. Similar results were found when the mammalian homolog
of one of these GTPases, Rab1, was expressed in an α-syn over-
expression model of PD in mammalian DA neurons (Cooper
et al., 2006). This study suggests that the aggregation of α-syn
FIGURE 4 | Model for roles of unfolded protein stress in
neurodegeneration. Under unmitigated stress, as may be the case in many
neurodegenerative diseases, the ER-UPR can induce cell death. The
disruption or malfunction of the ER-UPR may also contribute to the
development of important pathologies like neurodegenerative diseases.
Although the data is unclear, the ER-UPR may induce mitochondrial
stress (dashed line) through calcium signaling or other means. Mitochondrial
stress is well known to induce apoptosis and contribute to
neurodegeneration. We propose a model in which the MT-UPR stimulated by
protein misfolding that is characteristic of neurodegenerative diseases may
also play a role in cell death
(dashed line).
Frontiers in Aging Neuroscience www.frontiersin.org April 2012 | Volume 4 | Article 5 | 6
Bernales et al. Unfolded protein stress responses and neurodegeneration
in the ER inhibits a step of ER-to-Golgi trafficking likely lead-
ing to the accumulation of proteins in the ER and ER stress.
Interestingly α-syn misfolding has also been reported to inhibit
the UPS thereby leading to unfolded protein stress in the ER
(Cook and Petrucelli, 2009).
Studies of familial PD lend further support to the presence of
unfolded protein stress in the ER of affected cells. The cytoso-
lic protein parkin, a RING-finger containing E3 ubiquitin ligase,
has been proposed to function in the ERAD pathway by tar-
geting recently retrotranslocated misfolded ER proteins to the
proteasome (Imai et al., 2000; Meacham et al., 2001). Like many
ERAD components, parkin is transcriptionally regulated by the
ER-UPR, specifically by the transcription factor ATF4 (Bouman
et al., 2011). Mutations in the two RING domains of this pro-
tein are associated with the majority of cases of recessive familial
PD (Matsumine et al., 1997; Kitada et al., 1998). Many of these
mutations abolish the E3 ligase activity of parkin leading to the
accumulation of parkin targets in the ER and cytoplasm, suggest-
ing that this accumulation may be responsible for ER stress and
neuronal degeneration. Interestingly, parkin is thought to bind
and ubiquitinate α-syn in neurons (Shimura et al., 2001). Other
ERAD/UPS components may play roles in PD.Mutations in ubiq-
uitin carboxy-terminal hydrolase 1 (UCHL1) were reported to be
associated with the incidence of PD in one family, but this remains
controversial (Dauer and Przedborski, 2003; Schapira, 2006).
PD and the ER-UPR
The presence of unfolded protein stress in the ER suggests that
the ER-UPR should be activated in cells affected by PD. Indeed,
components of this pathway have been found to be activated
in post-mortem brain samples and experimental models of PD.
Levels of phosphorylated PERK (generally thought to be the acti-
vated form) and phosphorylated EIF2alpha were increased in the
substantia nigra region of PD patients (Hoozemans et al., 2007).
Recent data shows that BIP directly binds to α-syn in several cell-
based α-syn over-expression models of PD (Bellucci et al., 2011).
Additionally, the levels of BIP, as well as downstream ER-UPR sig-
naling molecules such as ATF4 and phosphorylated EIF2alpha,
are increased in such models (Smith et al., 2005; Bellucci et al.,
2011). Chemically induced cell and animal models of PD also
reveal activation of ER-UPR proteins such as the phosphorylation
of PERK and IRE1 and the upregulation of BIP, ATF4, and CHOP
(Holtz and O’Malley, 2003; Ryu et al., 2005; Silva et al., 2005).
While it is apparent that the ER-UPR is affected in PD, the con-
nection between the ER-UPR and neuronal cell death in PD is not
clear. The opposing functions of this pathway in maintaining cell
survival and inducing cell death mean its effects in disease are dif-
ficult to parse. The chronic activation of the ER-UPR could induce
cell death in affected neurons in PD patients or this pathway could
be upregulated in an attempt to alleviate unfolded protein stress
in the ER and promote cell survival. However, significant evidence
lends support for the direct involvement of the ER-UPR in neu-
ronal degeneration in PD. Chemical mimetic induction of PD
in cell or animal models induces not only the ER-UPR but also
apoptosis. Under these conditions, release of cytochrome c and
activation of caspases have been found to coincide with the acti-
vation of CHOP, a key regulator of ER-UPR-induced apoptosis
(Figure 2) (Holtz and O’Malley, 2003; Ryu et al., 2005; Silva et al.,
2005). Recent data reveals that the activation of the ER-UPR and
the initiation of apoptosis coincide in an α-syn over-expression
model of PD (Bellucci et al., 2011). Finally, CHOP expression
levels are increased in post-mortem brains of some PD patients
(Moisoi et al., 2009). Together these data suggest that the ER-
UPR could play an important role in the degeneration of neurons
during disease progression (Figure 4).
PD and mitochondrial stress
Mitochondrial stress and damage are classic symptoms of PD
and it is widely accepted that they contribute to the pathogene-
sis of this disease (Figure 4). Complex I of the electron transport
chain in the membrane of MT has been found to be dysfunctional
exclusively in neurons of the substantia nigra in post-mortem
brains of PD patients (Mann et al., 1994; Keeney et al., 2006).
Chemicals such as rotenone and MPP+, the active metabolite of
MPTP, which directly bind to and inhibit the activity of complex
I (Ramsay et al., 1991; Mao et al., 2012), mimic many PD symp-
toms in animal and cellular models of this disease. Reflecting the
damage to MT and complex I, reactive oxygen species (ROS) are
over-produced and oxidative stress has been detected in samples
from PD patients. Interestingly, while mitochondrial damaging
agents and gene mutations should affect most cells in the body,
only neurons in the substantia nigra and muscle cells are affected
in PD. Both neurons and muscle cells are significant energy con-
sumers and, therefore, depend heavily on MT for survival (Chen
and Chan, 2006). This could partially account for the sensitivity
of these particular cells to mitochondrial insults.
Studies of familial PD reveal further evidence of mitochon-
drial stress playing an important role in disease progression.
Mutations in the mitochondrial serine/threonine kinase PTEN-
induced putative kinase 1 (PINK1) correlate with disease inci-
dence (Valente et al., 2004a). Many of these mutations cluster
in the kinase domain of PINK1 and result in a non-functional
protein (Hatano et al., 2004; Rohe et al., 2004; Valente et al.,
2004a,b; Sha et al., 2010). Deficiencies of pink1 in Drosophila
lead to changes in mitochondrial morphology, increased sensi-
tivity to oxidative stress and reduced viability (Clark et al., 2006).
Additionally, over-expression of this kinase decreases the sensi-
tivity of cells to apoptotic stresses (Shavali et al., 2008) suggesting
that PINK1 has anti-apoptotic/pro-survival functions. PINK1 has
been shown to interact with parkin, which localizes to MT as well
as the cytoplasm. Although the mechanism has not been fully
elucidated, these proteins are thought to participate together in
regulating mitochondrial dynamics and quality control (Pridgeon
et al., 2007; Vives-Bauza et al., 2010).
PD and the MT-UPR
Increasing evidence of the involvement of mitochondrial stress,
mitochondrial proteinmisfolding, andmitochondrial chaperones
in PD indicate a role of the MT-UPR in this disease. Misfolded
proteins such as α-syn have been demonstrated to localize to and
accumulate in MT both in cell models of PD and in post-mortem
brains of PD patients (Devi et al., 2008; Shavali et al., 2008). It is
unclear whether this localization reflects a wild-type function of
α-syn or if it is aberrant and indicates cellular damage. The asso-
ciation of α-syn with MT triggers Ca2+ uptake by this organelle
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and oxidative damage (Parihar et al., 2008), suggesting that the
accumulation of this protein can induce mitochondrial dysfunc-
tion and apoptosis. PINK1 has been shown to interact with several
proteins involved with the MT-UPR and mitochondrial quality
control including TRAP1 (Pridgeon et al., 2007), HSP60 (Rakovic
et al., 2011) andHTRA2/OMI (Plun-Favreau et al., 2007) suggest-
ing that misregulation of PINK1 could generally affect protein
folding in MT. Indeed, it was shown recently that levels of mis-
folded mitochondrial respiratory components were increased in
post-mortem brains of PD patients carrying mutant alleles of
PINK1 (Pimenta de Castro et al., 2012). Correspondingly, the
levels of mitochondrial HSP60 were also upregulated in these
samples.
The mitochondrial protease OMI/HTRA2 also links the MT-
UPR to PD incidence and neurodegeneration. OMI/HTRA2
degrades misfolded proteins in the IMS and its activity is regu-
lated by phosphorylation by PINK1 (Plun-Favreau et al., 2007).
OMI/HTRA2 deficient mice display increased levels of aggre-
gated mitochondrial respiratory proteins (Moisoi et al., 2009)
and parkinsonian-like symptoms including heightened sensitiv-
ity to mitochondrial stress, increased ROS and cell death (Martins
et al., 2004). The lack of OMI/HTRA2 also resulted in a brain-
specific upregulation in the apoptosis regulator CHOP (Moisoi
et al., 2009). Finally, loss-of-function mutations in OMI/HTRA2
have been associated with PD incidence in a human population
(Strauss et al., 2005). Interestingly mutations in the mitochon-
drial folding chaperone HSP70 also associate with PD and expres-
sion of these mutant alleles affect mitochondrial function in cell
models (Burbulla et al., 2010).
It is difficult to prove whether the MT-UPR directly causes
neurodegeneration in PD. However, the significance of MT in
regulating apoptosis and the data described above suggest a
crucial link (Figure 4). Further investigation of the involve-
ment of other MT-UPR components could aid to dissect the
exact involvement of the MT-UPR in neurodegeneration and
PD. It would be interesting to determine whether CLPP and
other MT-UPR regulated genes are misexpressed during PD pro-
gression. Finally, further genetic studies could shed light on
whether mutations in other MT-UPR genes correlate with PD
incidence.
ALZHEIMER’S DISEASE
AD is characterized by the extracellular and intracellular depo-
sition of protein aggregates and neuronal death. These patholo-
gies are accompanied by loss of memory and dementia. Several
hypotheses have been proposed to explain the prominent neu-
ronal degeneration in AD. One hypothesis suggests that the
hallmark extracellular plaques of Aβ protein seen in brains
of AD patients are toxic and cause neuronal degeneration.
However, Aβ is constitutively secreted from neurons in brains
of seemingly healthy patients (Haass et al., 1992; Seubert et al.,
1992; Shoji et al., 1992). Other theories propose that intra-
cellular aggregates of Aβ or the microtubule-associated tau
protein are the toxic species that induce cell death. While
the underlying causes of neurodegeneration are unclear, neu-
rons of AD patients display oxidative damage, misregulation of
calcium signaling, and mitochondrial dysfunction in addition
to protein aggregation, suggesting that ER and mitochondrial
stress may be involved in the cell death (Figure 4) (Selkoe,
2011).
AD and ER stress
The presence of intracellular Aβ and tau deposits in neurons of
AD patients raises the possibility that ER stress is a key factor in
the progression of this disease. Aβ is a 37–43 amino acid prote-
olytic product of amyloid precursor protein (APP) (Reddy et al.,
2010; Haass et al., 2012), a transmembrane protein that is folded
and processed in the ER and is thought to participate in synapse
formation in neurons (Priller et al., 2006). APP is proteolized by
β- and γ-secretases to release Aβ fragments, but the functions of
these proteolytic products are unknown. Studies of Aβ localiza-
tion in neurons of AD patients and in mouse and cellular models
of AD reveal that in addition to the extracellular deposits, Aβ
oligomers localize to intracellular compartments including the
ER (Gouras et al., 2000; Fernandez-Vizarra et al., 2004). It has
been suggested that these aggregates may cause ER stress and
induce cell death. Consistent with this, studies of familial AD
have revealed disease causing mutations in APP that localize to
the β and γ cleavage sites (Selkoe, 2011). These mutations affect
APP processing and cause increased production of Aβ (primar-
ily Aβ40− and Aβ42 peptides) in the ER (Mao and Reddy, 2011;
Selkoe, 2011; Umeda et al., 2011).
AD and the ER-UPR
The involvement of the ER-UPR in the onset or progression
of AD appears to be complex. However, evidence suggests that
this pathway could be important for inducing neurotoxicity and
cell death (Figure 4). Consistent with Aβ aggregation in the ER,
levels of UPR components are generally upregulated in post-
mortem brain tissue from AD patients (Hoozemans et al., 2005).
Specifically, levels of PERK, phosphorylated PERK, and BIP were
found to be increased (Hoozemans et al., 2005). In a cell model of
AD, over-expression of mutant APP that produces large amounts
of Aβ sensitized cells to ER stress and ER stress-mediated tox-
icity (Chafekar et al., 2008). However, IRE1 activity and BIP
expression have been found to be reduced in models of AD
employing mutant alleles of presenilin 1 (PS1) and presenilin
2 (PS2) that are associated with familial AD (Katayama et al.,
1999; Terro et al., 2002). PS1 is a transmembrane protein located
in the ER and is a component of the γ-secretase complex that
cleaves APP to produce Aβ. In cell models expressing mutant
alleles of PS1, IRE1 induction, as measured through BIP levels,
has slower kinetics and is weaker (Katayama et al., 2001) while
levels of Aβ are increased (Duff et al., 1996). BIP is known to
bind APP in the ER of healthy cells as this transmembrane pro-
tein passes through the secretory pathway on its way to neuronal
synapses (Yang et al., 1998). Interestingly, the binding of BIP to
APP limits the production of the toxic Aβ, perhaps explaining the
excess of Aβ in cells with lower BIP expression. Finally, neurons
expressing mutant PS1 protein are more sensitive to ER stress
and undergo apoptosis at lower doses of ER-stress agents than
do wild type neurons (Guo et al., 1997). This could be due to
the decreased activity of IRE1 or the reduced levels of BIP and
suggests that the ER-UPR could be responsible for neurotoxicity
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in AD. In agreement with this idea, over-expression of Aβ is
less toxic in mice lacking caspase 12 (Nakagawa et al., 2000),
one of the caspases activated during ER-UPR induced apoptosis
(Figure 2).
The misregulation of Ca2+ signaling is another hallmark of
AD that suggests that the involvement of the ER-UPR in this
disease. Evidence from patients and experimental models indi-
cate that Ca2+ regulation is altered in early stages of AD. Aβ
oligomers have been found to trigger the release of Ca2+ from
the ER (Mattson et al., 1992; Ferreiro et al., 2004). Mutations in
PS1 have also been shown to cause misregulated calcium signal-
ing. PC-1 cells carrying a mutant allele of PS1 associated with
AD released significantly more calcium into the cytoplasm than
did control cells when they were treated with agonists that induce
Ca2+ release (Keller et al., 1998). Furthermore, cells expressing
mutant PS1 were hypersensitive to apoptosis, which was blocked
by the addition of calcium chelators suggesting that apoptosis
was induced by high cytosolic calcium levels (Keller et al., 1998).
The majority of cellular Ca2+ is stored in the ER and its release
activates the ER-UPR, in part because some ER folding chaper-
ones are calcium-dependent. Fluctuations in levels of cytosolic
Ca2+ trigger its uptake by MT and induce apoptosis. While it is
unclear whether Ca2+ misregulation is responsible for neurotox-
icity seen in AD, it suggests a potential link between the ER, MT,
and induction of apoptosis.
AD and mitochondrial stress
Mitochondrial damage as detected by the dysfunction of complex
I and increased oxidative stress are well-known characteristics of
AD. However, the underlying causes of this damage and its affects
on neurodegeneration are not fully understood. Aggregates of
Aβ have been localized to MT (Caspersen et al., 2005; Manczak
et al., 2006; Mao and Reddy, 2011; Umeda et al., 2011), but it
is unclear if this is the toxic agent because it has been suggested
that oxidative damage precedes this accumulation during AD
onset (Yao et al., 2009; Chang et al., 2011). On the other hand,
over-expression of Aβ in cell and mouse models of AD causes
oxidative damage, inhibits the activity of complex I and induces
cell death (Keil et al., 2004; Caspersen et al., 2005; Manczak
et al., 2006; Reddy et al., 2010). A recent study uncovered evi-
dence suggesting a direct link between Aβ accumulation in MT
and apoptosis (Lustbader et al., 2004). Aβ-binding alcohol dyhy-
drogenase (ABAD) is a mitochondrial matrix protein that binds
and whose function is inhibited by Aβ. Expression of ABAD has
been found to be increased in damaged neurons in brains of
patients with AD. In this study, authors detected the binding
of Aβ to ABAD in a mice over-expressing APP, the Aβ precur-
sor and in brain tissue of AD patients (Lustbader et al., 2004).
Inhibition of this binding ameliorated the oxidative damage,
mitochondrial toxicity and cell death in neurons expressing Aβ
peptide (Lustbader et al., 2004) and in a mouse model (Yao et al.,
2011). Furthermore, similar results were obtained when ABAD
was over-expressed in mice that also over-express APP. These data
provide a connection between the accumulation of Aβ aggre-
gates in MT and cell death and suggest a mode of cytotoxicity
in AD.
AD and the MT-UPR
Despite the evidence that mitochondrial stress plays a role in
precipitating neurotoxicity in AD, little is known about the
involvement of the MT-UPR in this process (Figure 4). It was
recently shown that the expression of the mitochondrial protease
OMI/HTRA2 is decreased in post-mortem brains of AD patients
(Westerlund et al., 2011). The specific activity of this enzyme was
found to be increased in the same samples. The same study uncov-
ered a weak association between a mutation in OMI/HTRA2
(A141S) and AD. It will be interesting to determine if this muta-
tion is found in other populations and whether the association
strengthens with the inclusion of more samples. OMI/HTRA2
interacts with Aβ (Park et al., 2004) and was shown to retard
Aβ aggregation in vitro (Kooistra et al., 2009) suggesting that
mutations in OMI/HTRA2 could play a role AD. We suggest that
other components of the MT-UPR such as mitochondrial chap-
erones and proteases could be misregulated or be involved in the
progression of this disease. It would be intriguing to determine,
for example, whether over-expression of mitochondrial HSP60
affects the deposition of Aβ in MT and cell toxicity. Such stud-
ies could provide novel therapeutic targets for neurodegenerative
diseases.
SUMMARY
Protein misfolding and aggregation as well as the upregulation
of the ER-UPR and mitochondrial dysfunction are classic etiolo-
gies of many neurodegenerative diseases suggesting a general role
for UPRs in inducing cell death in these diseases. This notion
is supported by studies of hereditary spastic paraplegia (SPG),
a degenerative disease of the upper motor neurons involved in
voluntary movement. The incidence of this disease is associated
with mutations in the mitochondrial HSP60 and protease SPG7
(Haynes and Ron, 2010). The expression of CLPP has been found
to be reduced in some cases of SPG (Hansen et al., 2008). The ER-
UPR is also reported to be upregulated in cases of ALS (Doyle
et al., 2011), a fatal neurodegenerative disease that affects pri-
marily motor neurons and is associated with the accumulation of
aggregates of ubiquitin, a mutant form of superoxide dismutase
1 (mSOD1) and the ER chaperone, PDI. Despite the evidence of
the involvement of unfolded protein stress response pathways in
the ER andMT in neurodegeneration, it remains unclear whether
these pathways are responsible for the cell death associated with
these diseases or are upregulated as a consequence of other toxic
effects.
The involvement of the ER-UPR in life-death decisions has
been well documented. It is thought that early activation of the
ER-UPR triggers pro-survival signals such as folding chaperones
to increase the folding capacity of the cell. Chronic activation of
this pathway, however, is thought to generate pro-apoptotic sig-
nals through the PERK branch and induce cell death. It is not well
understood how these two opposing forces are balanced. Unlike
the ER-UPR, the connection between the MT-UPR and induc-
tion of apoptosis is not known and further investigation is needed
to determine whether saturation of the MT-UPR can induce cell
death in a manner similar to that of the ER-UPR. We propose,
however, that evidence suggests that protein misfolding in MT
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in neurodegenerative diseases could participate in inducing neu-
rodegeneration. Establishing a firm connection between the neu-
rotoxicity typical of neurodegenerative diseases such as AD and
PD and the activation of the cellular unfolded protein stress
responses including the MT-UPR could prove invaluable for
developing novel therapeutics to treat these diseases.
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